Anson Medical gears up distribution network:
This article was originally published in Clinica
Lombard Medical subsidiary Anson Medical has formed distribution agreements in Italy, Ireland and South Africa for its Aorfix device for the endovascular treatment of abdominal aortic aneurysms (AAA). The deals are with Seda of Milan, Italy, Unitech of Dublin, and Viking Medical and Scientific of Edenglen (South Africa). Anson's CEO Dr Peter Philips said the company is assessing a number of other distribution possibilities and plans to have the majority of its worldwide distribution network established over the next few months.
You may also be interested in...
Indoco’s domestic performance picks up pace as the Indian pharma market sees a “bounce back” after a long COVID-induced slump. The Indian company continues to perform well internationally and grow overall.
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Development Partners International, CDC Group and the European Bank for Reconstruction and Development have collaborated to create a “first of its kind, pan-African” generics platform built on the acquisition and combination of Egypt’s Adwia Pharmaceuticals and India’s Celon Laboratories. An initial $250m investment is to be followed by up to $500m in further funding.